about
Burkitt lymphoma in adolescents and young adults: management challenges.Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental SignalingHigh-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.Strategies to Inhibit Myc and Their Clinical ApplicabilityHepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.Targeting MYC: is it getting any easier?Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4+ T cells by targeting Myc in patients with dilated cardiomyopathy.Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1.MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent.Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells.Gastric Cancer Cell Lines Have Different -Regulated Expression Patterns but Share a Common Core of Altered GenesCovalent CDK7 Inhibitor THZ1 Inhibits Myogenic Differentiation
P2860
Q30238965-18089D13-8A54-47C1-95DC-366CB38F823DQ33608508-0416085C-19A3-4D63-9199-45E9F2F130B1Q36178314-79BCB894-3E7C-4549-BAC1-F8CAEBA44828Q36303678-AEED9A85-B7F3-476A-BD2D-7123FA46AACBQ37316239-F23F1EEE-1067-40A9-9C6B-21439CB0CD29Q38819081-2BB33F2E-3C02-4C17-91A2-F0480F7B075CQ39100521-7231219A-0FFC-42C0-BB69-EB8534B33A41Q46985603-3884951D-BAAD-473B-A2FC-03FBF47C41D3Q47212126-39C4BD5D-C684-4B8B-B073-0B361C919B05Q47797194-9ACDE7E9-D189-43DF-A1C6-1120E4FD0062Q49500445-CE888992-3996-4A89-9BE9-57C7A4364794Q49791794-823BC481-88B1-4F6E-8E4F-619D857A67B2Q51320385-DA3C3A58-7330-4BA2-BE79-F94EB4429AADQ52694952-1EF64EA2-FE89-4B10-AEEF-6D0909A5FC6EQ55248424-969E28DE-9D42-4322-85D1-65625DAFE2F9Q58551710-DC7E2D8C-765B-419C-8AE9-525C96BEBB22Q58798336-CBEDA7DB-6F05-44B1-9EC9-63BDF0697390
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Strategically targeting MYC in cancer
@ast
Strategically targeting MYC in cancer
@en
Strategically targeting MYC in cancer
@nl
type
label
Strategically targeting MYC in cancer
@ast
Strategically targeting MYC in cancer
@en
Strategically targeting MYC in cancer
@nl
prefLabel
Strategically targeting MYC in cancer
@ast
Strategically targeting MYC in cancer
@en
Strategically targeting MYC in cancer
@nl
P2860
P3181
P1433
P1476
Strategically targeting MYC in cancer
@en
P2093
Michael D Cole
Valeriya Posternak
P2860
P3181
P356
10.12688/F1000RESEARCH.7879.1
P407
P577
2016-01-01T00:00:00Z